4.7 Article

Biological activity of heterologous murine interleukin-10 and preliminary studies on the use of a dextrin nanogel as a delivery system

Journal

INTERNATIONAL JOURNAL OF PHARMACEUTICS
Volume 400, Issue 1-2, Pages 234-242

Publisher

ELSEVIER
DOI: 10.1016/j.ijpharm.2010.08.040

Keywords

Protein delivery system; Anti-inflammatory cytokine; Interleukin-10; Endotoxin-activated macrophages; Dextrin nanogel

Funding

  1. Fundacao para a Ciencia e Tecnologia (FCT), Portugal [SFRH/BD/27359/2006]
  2. FCT [PTDC/BIO/67160/2006]
  3. Fundação para a Ciência e a Tecnologia [PTDC/BIO/67160/2006, SFRH/BD/27359/2006] Funding Source: FCT

Ask authors/readers for more resources

Interleukin-10 (IL-10) is an anti-inflammatory cytokine, which active form is a non-covalent homodimer with two intramolecular disulphide bonds essential for its biological activity. A mutated form of murine IL-10 was successfully expressed in E. coli, recovered and purified from inclusion bodies. Its ability to reduce tumor necrosis factor alpha synthesis and down-regulate class II major histocompatibility complex molecules expression on endotoxin-stimulated bone marrow-derived macrophages was confirmed, and shown to be similar to that of a commercially available IL-10. Given the potential of IL-10 for application in various medical conditions, it is essential to develop systems that can effectively deliver the protein. In this work it is shown that a dextrin nanogel effectively incorporate IL-10, stabilize, and enable the slow release of biologically active IL-10 over time. Altogether, these results demonstrate the suitability of dextrin nanogel to be used as a system for the controlled release of IL-10. (C) 2010 Elsevier B.V. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available